Carvolix Overview
- Year Founded
-
2011
- Status
-
Public
- Employees
-
102
- Stock Symbol
-
CVX
- Investments
-
2
- Share Price
-
$5.36
- (As of Friday Closing)
Carvolix General Information
Description
Carvolix SA specializes in the development of AI-based mini-robots and biomimetic implants designed to autonomously replace heart valves and treat strokes.
Contact Information
Website
www.carvolix.euCorporate Office
- 320 Avenue Archimede
- Les pleiades III Batiment B
- 13100 Aix en Provence
- France
Corporate Office
- 320 Avenue Archimede
- Les pleiades III Batiment B
- 13100 Aix en Provence
- France
Carvolix Timeline
Carvolix Stock Performance
As of 13-Nov-2026, Carvolix’s stock price is $5.36. Its current market cap is $333M with 62.2M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.36 | $5.48 | $1.56 - $8.63 | $333M | 62.2M | 26.7K | -$0.72 |
Carvolix Financials Summary
As of 31-Dec-2025, Carvolix has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Dec-2025 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 100,336 | 100,336 | 71,709 | 83,968 |
| Revenue | 0 | 0 | 4,456 | 0 |
| EBITDA | (24,259) | (24,259) | (12,952) | (14,046) |
| Net Income | (28,167) | (28,167) | (15,949) | (16,938) |
| Total Assets | 63,327 | 62,650 | ||
| Total Debt | 0 | 0 | 16,991 | 18,609 |
Carvolix Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Carvolix Comparisons
Industry
Financing
Details
Carvolix Competitors (2)
One of Carvolix’s 2 competitors is Occlutech, a Formerly PE-Backed company based in Helsingborg, Sweden.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Occlutech | Formerly PE-Backed | Helsingborg, Sweden | ||||
| Corcym | Private Equity-Backed | Milan, Italy |
Carvolix Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Carvolix Patents
Carvolix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3654881-B1 | Adjustable percutaneous annuloplasty devices and delivery systems for percutaneously deploying an annuloplasty device and a method performed by one or more processing devices | Active | 18-Jul-2017 | ||
| EP-3654881-C0 | Adjustable percutaneous annuloplasty devices and delivery systems for percutaneously deploying an annuloplasty device and a method performed by one or more processing devices | Active | 18-Jul-2017 | ||
| AU-2017423569-A1 | Adjustable percutaneous annuloplasty devices, delivery systems, a method for percutaneously deploying an annuloplasty device and a method performed by one or more processing devices | Inactive | 18-Jul-2017 | ||
| EP-3654881-A1 | Adjustable percutaneous annuloplasty devices, delivery systems, a method for percutaneously deploying an annuloplasty device and a method performed by one or more processing devices | Active | 18-Jul-2017 | ||
| WO-2019015747-A1 | Adjustable percutaneous annuloplasty devices, delivery systems, a method for percutaneously deploying an annuloplasty device and a method performed by one or more processing devices | Inactive | 18-Jul-2017 | A61F2/2448 |
Carvolix Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Carvolix Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Carvolix Acquisitions (2)
Carvolix’s most recent deal was a Merger/Acquisition with Caranx Medical for . The deal was made on 30-Jan-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Caranx Medical | 30-Jan-2026 | Merger/Acquisition | Therapeutic Devices | ||
| Artedrone | 18-Dec-2025 | Merger/Acquisition | Surgical Devices |
Carvolix ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Software & Services
Industry
Rank
Percentile
Enterprise and Infrastructure Software
Subindustry
Rank
Percentile
Carvolix FAQs
-
When was Carvolix founded?
Carvolix was founded in 2011.
-
Where is Carvolix headquartered?
Carvolix is headquartered in Aix en Provence, France.
-
What is the size of Carvolix?
Carvolix has 102 total employees.
-
What industry is Carvolix in?
Carvolix’s primary industry is Therapeutic Devices.
-
Is Carvolix a private or public company?
Carvolix is a Public company.
-
What is Carvolix’s stock symbol?
The ticker symbol for Carvolix is CVX.
-
What is the current stock price of Carvolix?
As of 13-Nov-2026 the stock price of Carvolix is $5.36.
-
What is the current market cap of Carvolix?
The current market capitalization of Carvolix is $333M.
-
Who are Carvolix’s competitors?
-
What is Carvolix’s annual earnings per share (EPS)?
Carvolix’s EPS for 12 months was -$0.72.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
